Lung perfusion scan to guide radiation planning for lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study compares two ways of planning radiation treatment for lung tumors. One method uses a special scan to see which parts of your lungs work best, aiming to protect healthy lung tissue, while the other uses a standard anatomical approach. The goal is to see if the functional approach can reduce side effects and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must be scheduled to receive a type of high-precision radiation treatment called stereotactic body radiotherapy (SBRT) for a lung tumor (either the main or a secondary tumor).
- You must not have any medical reason that would prevent you from receiving the radioactive tracer used in the lung perfusion scan.
- You must be able to give your own informed consent (not under guardianship or legal protection).
- If you are a woman, you must not be pregnant or breastfeeding during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a more precise radiation technique (stereotactic body radiotherapy) for early-stage lung cancer or small lung tumors. It aims to reduce side effects by eliminating the usual safety margin around the tumor.
This trial tests a new way to plan radiation therapy for lung cancer by using a special imaging technique (functional lung imaging) to see which parts of your lungs work best. The goal is to reduce damage to healthy lung tissue while still targeting the cancer.
This study tests a new way to plan radiation for lung tumors. It uses a breathing-guided scan to map healthy and unhealthy parts of the lungs, so radiation can avoid working lung tissue. The goal is to see if this approach spares more healthy lung while still treating the cancer.
This study tests a special imaging-guided radiation plan that aims to treat lung cancer while reducing radiation to healthy lung tissue. It may help lower lung side effects while keeping the cancer treatment focused on tumor areas.
This study uses a special PET imaging scan to help doctors see how well pembrolizumab (an immunotherapy drug) is working against advanced non-small cell lung cancer. You'll receive the scan along with your regular pembrolizumab treatment and possible radiation therapy to help measure treatment response.
This study uses an AI tool to help plan how doctors deliver focused radiation to lung tumors. It may help make radiation targeting more precise and support treatment safety for people with primary or limited metastatic lung cancer.
Hear when a new Stereotactic Body Radiotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.